|
20.06.25 - 07:03
|
Combined Shareholders′ Meeting of June 19, 2025: All Submitted Resolutions Were Adopted (Business Wire)
|
|
NEUILLY-SUR-SEINE, France--(BUSINESS WIRE)--The Combined Shareholders' Meeting of Bureau Veritas (the "Company"), chaired by Mr. Laurent Mignon, Chairman of the Board of directors, was held today at the Company's head office.
All resolutions submitted to the Shareholders' Meeting were adopted at a large majority, including:
The approval of the statutory and consolidated financial statements for the financial year ending on December 31, 2024, and the approval of a dividend distribution of €0.90 per share to be paid in cash on July 3, 2025 (ex-date on July 1, 2025) on positions closed on July 2, 2025;
The approval of a related-party agreement concerning the Company's participation in Wendel's share placement (acquisition by the Company of its own shares);
The approval of the report on Corporate Officers' compensation;
The approval of fixed, variable and extraordinary components of the total compensation and benefits-in-kind paid or awarded for the 2024 financial year to Mr. Laurent Mignon,...
|
|
|
14.05.25 - 13:03
|
GT Biopharma Appoints New Member to its Board of Directors (GlobeNewswire EN)
|
|
SAN FRANCISCO, CALIFORNIA, May 14, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer (NK) cell engager platform, today announced the appointment of Hilary Kramer to its Board of Directors. Mrs. Kramer will be replacing current board member Bruce Wendel, who is resigning his position....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|